|
Market Closed -
NYSE
16:10:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 52.91 USD | -0.26% |
|
-5.10% | +37.22% |
Investment objective
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 9.470USD | -56.58% | -2.97% | 1.87% | |
| 14.27USD | +1.64% | +85.32% | 1.6% | |
| 4.500USD | -4.05% | +90.68% | 1.38% | |
| 14.00USD | +0.14% | +55.04% | 1.32% | |
| 115.07USD | +0.03% | +76.49% | 1.23% | |
| 58.02USD | +0.07% | +71.30% | 1.22% | |
| 25.30USD | +1.08% | -3.77% | 1.14% | |
| 12.68USD | -0.35% | +41.10% | 1.13% | |
| 1.985USD | -0.75% | +44.89% | 1.07% | |
| 22.35USD | -2.15% | +152.26% | 1.06% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | US$52.91 | -0.26% | 8,227 |
| 26-08-31 | US$53.05 | -0.46% | 32,466 |
| 26-08-28 | US$53.29 | -3.69% | 18,256 |
| 26-08-27 | US$55.34 | +0.34% | 20,513 |
| 26-08-26 | US$55.15 | -1.09% | 37,343 |
Description
| US26923G3011 | |
|---|---|
| Total Expense Ratio | 0.0065 |
| Asset Class | Stocks |
| Geographical Zones | |
| Currency | |
| Provider | |
| Underlying | LifeSci Biotechnology Clinical Trials Total Return Index - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Date of creation |
2014-12-15
|
| Geographical Focus |
AuM evolution - 2026-08-11
| AuM (USD) | 58.16M |
|---|---|
| AuM 1M | 58.16M |
| AuM 3 months | 58.16M |
| AuM 6 months | 58.16M |
| AuM 12 months | 58.16M |
- Stock Market
- ETF
- BBC ETF
Select your edition
All financial news and data tailored to specific country editions
